Goode, PhD, President & Chief Executive Officer of Glucotrack. "With these positive ... device related serious adverse events reported from implant through seven days post-removal of the CBGM ...

RUTHERFORD, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and ...

Glucotrack (GCTK),announced that Guillermo Umpierrez, MD, CDCES, FACE, MACP, has been named as Glucotrack’s new Medical Advisory Board member, effective immediately. See what stocks are ...

RUTHERFORD, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people ...

RUTHERFORD, NJ – Glucotrack, Inc. (NASDAQ:GCTK), a medical device company with a market capitalization of $3.54 million, disclosed the completion of several transactions involving unregistered ...

RUTHERFORD, NJ – Glucotrack, Inc. (NASDAQ:GCTK), a medical device company with a market capitalization of $3.54 million, disclosed the completion of several transactions involving unregistered sales ...

Glucotrack, Inc. GCTK reports it has achieved a significant milestone in its mission to transform diabetes management through three distinct advances: direct blood glucose measurement, hassle-free ...

Leading diabetes researcher and clinician joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technologyRUTHERFORD, N.J., Feb. 26, 2025 (GLOBE ...

(MENAFN- GlobeNewsWire - Nasdaq) Leading diabetes researcher and clinician joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technology RUTHERFORD ...